Literature DB >> 16820438

citrate inhibition-resistant form of 6-phosphofructo-1-kinase from Aspergillus niger.

Tina Mlakar1, Matic Legisa.   

Abstract

Two forms of Aspergillus niger 6-phosphofructo-1-kinase (PFK1) have been described recently, the 85-kDa native enzyme and 49-kDa shorter fragment that is formed from the former by posttranslational modification. So far, kinetic characteristics have never been determined on the enzyme purified to near homogeneity. For the first time, kinetic parameters were determined for individual enzymes with respect to citrate inhibition. The native 85-kDa enzyme was found to be moderately inhibited by citrate, with the Ki value determined to be 1.5 mM, in the system with 5 mM Mg2+ ions, while increasing magnesium concentrations relieved the negative effect of citrate. An identical inhibition coefficient was determined also in the presence of ammonium ions, although ammonium acted as a strong activator of enzyme activity. On the other hand, the shorter fragment of PFK1 proved to be completely resistant to inhibition by citrate. Allosteric citrate binding sites were most probably lost after the truncation of the C-terminal part of the native protein, in which region some binding sites for inhibitor are known to be located. At near physiological conditions, characterized by low fructose-6-phosphate concentrations, a much higher efficiency of the shorter fragment was observed during an in vitro experiment. Since the enzyme became more susceptible to the positive control by specific ligands, while the negative control was lost after posttranslational modification, the shorter PFK1 fragment seems to be the enzyme most responsible for generating undisturbed metabolic flow through glycolysis in A. niger cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16820438      PMCID: PMC1489355          DOI: 10.1128/AEM.00539-06

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  27 in total

1.  CITRATE INHIBITION OF PHOSPHOFRUCTOKINASE AND THE PASTEUR EFFECT.

Authors:  M L SALAS; E VINUELA; M SALAS; A SOLS
Journal:  Biochem Biophys Res Commun       Date:  1965-04-23       Impact factor: 3.575

2.  Phosphofructokinase from Fasciola hepatica: activation by phosphorylation and other regulatory properties distinct from the mammalian enzyme.

Authors:  E S Kamemoto; M H Iltzsch; L Lan; T E Mansour
Journal:  Arch Biochem Biophys       Date:  1987-10       Impact factor: 4.013

3.  Overexpression of phosphofructokinase and pyruvate kinase in citric acid-producing Aspergillus niger.

Authors:  G J Ruijter; H Panneman; J Visser
Journal:  Biochim Biophys Acta       Date:  1997-03-15

4.  Kinetic properties of ATP-dependent phosphofructokinase from grapefruit juice sacs: effect of TCA cycle intermediates.

Authors:  E Van Praag; U Zehavi; R Goren
Journal:  Biochem Mol Biol Int       Date:  1999-05

5.  Posttranslational modification of 6-phosphofructo-1-kinase in Aspergillus niger.

Authors:  Suzana Mesojednik; Matic Legisa
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

6.  Evolution of phosphofructokinase--gene duplication and creation of new effector sites.

Authors:  R A Poorman; A Randolph; R G Kemp; R L Heinrikson
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

7.  Phosphofructokinase from liver of the rainbow trout, Oncorhynchus mykiss.

Authors:  J Y Su; K B Storey
Journal:  Arch Biochem Biophys       Date:  1993-04       Impact factor: 4.013

8.  Evidence for the activation of 6-phosphofructo-1-kinase by cAMP-dependent protein kinase in Aspergillus niger.

Authors:  M Legisa; M Bencina
Journal:  FEMS Microbiol Lett       Date:  1994-05-15       Impact factor: 2.742

9.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

10.  Amino acid sequence at the citrate allosteric site of rabbit muscle phosphofructokinase.

Authors:  R G Kemp; R W Fox; S P Latshaw
Journal:  Biochemistry       Date:  1987-06-16       Impact factor: 3.162

View more
  9 in total

1.  Systems-level analysis of mechanisms regulating yeast metabolic flux.

Authors:  Sean R Hackett; Vito R T Zanotelli; Wenxin Xu; Jonathan Goya; Junyoung O Park; David H Perlman; Patrick A Gibney; David Botstein; John D Storey; Joshua D Rabinowitz
Journal:  Science       Date:  2016-10-27       Impact factor: 47.728

2.  Evolution of allosteric citrate binding sites on 6-phosphofructo-1-kinase.

Authors:  Aleksandra Usenik; Matic Legiša
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

3.  Posttranslational modification of 6-phosphofructo-1-kinase as an important feature of cancer metabolism.

Authors:  Andreja Šmerc; Eva Sodja; Matic Legiša
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240

4.  Ethyl Pyruvate Modulates Murine Dendritic Cell Activation and Survival Through Their Immunometabolism.

Authors:  Marita Chakhtoura; Robert W Chain; Priscila Y Sato; Connie C Qiu; Michael H Lee; Joseph J Meissler; Toby K Eisenstein; Walter J Koch; Roberto Caricchio; Stefania Gallucci
Journal:  Front Immunol       Date:  2019-01-28       Impact factor: 7.561

5.  Staphylococcus aureus induces an itaconate-dominated immunometabolic response that drives biofilm formation.

Authors:  Kira L Tomlinson; Tania Wong Fok Lung; Felix Dach; Medini K Annavajhala; Stanislaw J Gabryszewski; Ryan A Groves; Marija Drikic; Nancy J Francoeur; Shwetha H Sridhar; Melissa L Smith; Sara Khanal; Clemente J Britto; Robert Sebra; Ian Lewis; Anne-Catrin Uhlemann; Barbara C Kahl; Alice S Prince; Sebastián A Riquelme
Journal:  Nat Commun       Date:  2021-03-03       Impact factor: 14.919

6.  Overexpression of a modified 6-phosphofructo-1-kinase results in an increased itaconic acid productivity in Aspergillus niger.

Authors:  Laura van der Straat; Juan A Tamayo-Ramos; Tom Schonewille; Leo H de Graaff
Journal:  AMB Express       Date:  2013-09-13       Impact factor: 3.298

7.  Model-Based Assessment of Plasma Citrate Flux Into the Liver: Implications for NaCT as a Therapeutic Target.

Authors:  Z Li; D M Erion; T S Maurer
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-03-04

8.  Targeting the sugar metabolism of tumors with a first-in-class 6-phosphofructo-2-kinase (PFKFB4) inhibitor.

Authors:  Jason Chesney; Jennifer Clark; Lilibeth Lanceta; John O Trent; Sucheta Telang
Journal:  Oncotarget       Date:  2015-07-20

9.  Analysis of the regulatory mechanism of deoxynivalenol production using omics.

Authors:  Yumiko Iwahashi
Journal:  AMB Express       Date:  2018-10-03       Impact factor: 3.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.